Rare diseases
Investigational molecules
Locations
A study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk
GermanyA Study of Lifileucel with Cyclophosphamide, Fludarabine, and Aldesleukin for Adults with Previously Treated Advanced Melanoma
GermanyA Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer
GermanyTesting Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition
GermanyStudy of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment
GermanyA Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment
GermanyA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
GermanyA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
GermanyStudy of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo
GermanyStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
GermanyStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
GermanyStudy of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
